Charlotte Micheloud

Oct 29, 2024 | onlinelibrary.wiley.com | Charlotte Micheloud |Leonhard Held

1 Introduction Replicability of scientific findings is the gold standard for assessing their credibility. Recent years have witnessed an increased interest in large-scale replication projects, aiming to reproduce the results found in an original study in one or several replication studies. Various empirical domains of science are involved in these replication efforts: psychology (Open Science Collaboration 2015), social sciences (Camerer et al. 2016), economics (Camerer et al.

May 13, 2024 | elifesciences.org | Samuel Pawel |Rachel Heyard |Charlotte Micheloud |Leonhard Held

eLife assessment This work provides a valuable contribution and assessment of what it means to replicate a null study finding, and what are the appropriate methods for doing so (apart from a rote p-value assessment).

Jun 20, 2023 | onlinelibrary.wiley.com | Charlotte Micheloud |Fadoua Balabdaoui |Leonhard Held

1 INTRODUCTION Replication plays a key role to build confidence in the scientific merit of published results. The so-called replication crisis has led to increased interest in replication studies over the last decade (National Academies of Sciences, Engineering, and Medicine, 2019; Royal Netherlands Academy of Arts and Science, 2018) with large-scale replication projects being conducted in various fields (Camerer et al., 2016, 2018; Errington et al., 2021; Open Science Collaboration, 2015).

Apr 28, 2023 | onlinelibrary.wiley.com | Manja Deforth |Charlotte Micheloud |Kit C. Roes |Leonhard Held

1 INTRODUCTION There are several ways how a new treatment can obtain market approval by regulatory agencies. Confirmatory clinical evidence for the effectiveness of a drug is usually required, and often includes some evidence of robustness.